Echocardiographic assessment of subclinical left ventricular eccentric hypertrophy in adult-onset GHD patients by geometric remodeling: An observational case-control study

BMC Endocrine Disorders

Volumn 6, Issue , 2006, Pages

  de Gregorio, Cesare ^a   Curtò, Lorenzo ^a   Recupero, Antonino ^a   Grimaldi, Patrizia ^a   Almoto, Barbara ^a   Venturino, Marilena ^a   Cento, Domenico ^a   Narbone, Maria Carola ^a   Trimarchi, Francesco ^a   Coglitore, Sebastiano ^a   Cannavò, Salvatore ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; LIOTHYRONINE; SOMATOMEDIN C; THYROXINE;

ADULT; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIOPHARYNGIOMA; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EMPTY SELLA SYNDROME; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GEOMETRY; GROWTH HORMONE DEFICIENCY; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBESITY; OBSERVATIONAL STUDY; PROGNOSIS; REST; SYSTOLIC BLOOD PRESSURE; THYROXINE BLOOD LEVEL;

EID: 33745584830     PISSN: 14726823     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-6-1     Document Type: Article

References (39)

1. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Saccà L, Bellastella A: Body composition, bone metabolism, heart structure and function in growth hormone deficient adult before and after growth hormone replacement therapy at low doses. J Clin Endocrinol Metab 1993, 77(6):1671-1676.
2. Carrol PV, Christ E, the members of Growth Hormone Research Society Scientific Committee, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorner M: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. J Clin Endocrinol Metab 1998, 83(2):382-395.
3. Jorgensen JOL, Muller J, Moller J, Wolthers T, Vahl N,Juul A, Skakkerbaek NE, Christiansen JS: Adult growth hormone deficiency. Horm Res 1994, 42:235-241.
4. Saccà L, Cittadini A, Fazio S: Growth hormone and heart. Endocr Rev 1994, 15(5):555-573.
5. Colao A, Vitale G, Pivonello R, Ciccarelli A, Di Somma C, Lombardi G: The heart: an end-organ of GH action. Eur J Endocrinology 2004, 151(suppl 1):S93-S101.
6. De Boer H, Block GJ, Van Der Veen E: Clinical aspects of growth hormone deficiency. Endocr Rev 1995, 16:63-86.
7. Colao A, Marzullo P, Di Somma C, Lombardi G: Growth hormone and the heart. Clin Endocrinol (Oxf) 2001, 54:137-154.
8. Merola B, Cittadini A, Colao A, Longobardi S, Fazio S, Sabatini D, Saccàa L, Lombardi G: Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab 1993, 77(6):1658-1661.
9. Cittadini A, Cuocolo A, Merola B, Merla B, Fazio S, Sabatini D, Nicolai E, Colao A, Longobardi S, Lombardi G, Saccà L: Impaired cardiac performance in GH deficient adults and its improvement after GH replacement. Am J Physiol 1994, 267:E219-E225.
10. Fazio S, Cittadini A, Sabatini D, Merla B, Colao A, Biondi B, Lombardi G, Saccà L: Growth hormone and heart performance: a novel mechanism of cardiac wall stress regulation in humans. Eur Heart J 1997, 18:340-347.
11. Shahi M, Beshyah SA, Hackett D, Sharp P, Jonhston DG, Foale RA: Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J 1992, 67(1):92-96.
12. Colao A, Cuocolo A, Di Somma C, Cerbone G, Morte AM, Pivonello R, Nicolai E, Salvatore M, Lombardi G: Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study. Clin Endocrinol (Oxf) 2000, 52(4):447-455.
13. Rosèn T, Bengtsson BA: Premature mortality due to cardiovascular diseases in hypopituitarism. A study of 333 consecutive patients. Lancet 1990, 336:285-288.
14. Bates AS, Van't Hoff W, Jones PJ, Clayton RN: The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996, 81:1169-1172.
15. Lombardi G, Colao A, Marzullo P, Ferone D, Longobardi S, Esposito V, Merla B: Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly. J Endocrinol 1997, 155:S33-S37.
16. Daousi C, Dunn AJ, Foy PM, MacFarlane IA, Pinkney JH: Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage. Am J Med 2005, 118(1):45-50.
17. Chanson P: Atteinte cardiovasculaire au cours du deficit en hormone de croissance (GH) chez I'adulte et effets du traitement substitutif par hormone de croissance. Sang Thromb Vaiss 1995, 7:441-453.
18. Salerno M, Esposito V, Spinelli L, Di Somma C, Farina V, Muzzica S, de Horatio I, Lombardi G, Colao A: Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy. Clin Endocrinol (Oxf) 2004, 60(5):630-636.
19. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322(22):1561-1566.
20. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991, 114(5):345-352.
21. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH: Patterns of left ventricular hypertrophy and geometric remodeling in arterial hypertension. J Am Coll Cardial 1992, 19(7):1559-1560.
22. Devereux RB, Roman MJ: Prognostic significance of left ventricular hypertrophy and its regression [Significato prognostico dell'ipertrofia ventricolare sinistra e della sua regressione]. In Ipertrofia del cuore e dei vasi nell'ipertensione Edited by: Ganau A, Saba PS, Roman MJ, Devereux RB. Italian Society of Cardiology, Rome (Italy), Novate (Milan); 2002:159-193.
23. de Simone G, Devereux RB, Kimball TR, Mureddu GF, Roman MJ, Contaldo F, Daniels SR. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 1998, 31:1077-1082.
24. Ghigo E, Aimaretti G, Corneli G, Bellone J, Arvat E, Maccario M, Capanni F: Diagnosis of GH deficiency in adults. Growth Horm IGF Res 1998, 8(Suppl A):55-58.
25. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr. Roccella EJ, Joint National Committee on Prevention Detection Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42(6):1206-1252.
26. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I: Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiography 1989, 2(5):358-367.
27. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH: Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cordiol 1994, 23:1444-1551.
28. European Study Group on Diastolic Heart Failure: How to diagnose diastolic heart failure. Eur Heart J 1998, 19:990-1003.
29. de Simone G, Verdecchia P, Pede S, Gorini M, Maggioni AP, on behalf of the MAVI Investigators: Prognosis of Inappropriate Left Ventricular Mass in Hypertension. The MAVI Study. Hypertension 2002, 40:470-476.
30. Ozbey N, Sezgil A, Oflaz H, Umman B, Orhan Y, Sencer E, Molvalilar S: Left ventricular function abnormalities in hypopituitary patients with GH deficiency: Evidence for a subclinical cardiomyopathy. J Endocrinol Invest 2002, 25(7):590-597.
31. Colao A, Di Somma C, Cuocolo A, Filippella M, Rota F, Acampa W, Savastano S, Salvatore M, Lombardi G: The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: An observational, case-control study. J Clin Endocrinol Metab 2004, 89(12):5998-6004.
32. Abdu T AM, Neary R, Elhadd TA, Akber M, Clayton RN: Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clin Endocrinol (Oxf) 2001, 55(5):699.
33. Sassolas G, Chazot FB, Jaquet P, Bachelot I, Chanson P, Rudelli CC, Tauber JP, Allannic H, Bringer J, Roudaut N, Rohmer V, Roger P, Latapie JL, Reville P, Leutenegger M: Growth hormone deficiency in adults: an epidemiological approach. Eur J Endocrinol 1999, 141(6):595-600.
34. Khan AS, Sane DC, Wannenburg T, Sonntag WE: Growth hormone, insuline-like growth factor-I and the aging cardiovascular system. Cardiovasc Res 2002, 54:25-35.
35. Lissett CA, Jönssor P, Monson JP, Shalet SM, KIMS International Board: Determinants of IGF-1 status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of onset of GHD. Clin Endocrinol (Oxf) 2003,59(6):773-776.
36. McCallum RW, Petrie JR, Dominiczak AF, Connell JMC: Growth hormone deficiency and vascular risk. Clin Endocrinol 2002, 57:11-24.
37. Maison P, Balkau B, Simon D, Chanson P, Rosselin G, Eschwege E: Growth hormone as a risk for premature mortalityin heathy subjects: data from the Paris prospective study. BMJ 1998, 316(7138):1132-1133.
38. Cavalli G, de Gregorio C, Nicosia S, Cannavò S, Aragona A, Trimarchi F, Arrigo F, de Gregorio G: [Acromegalic cardiomyopathy. a morpho-functional study with color Doppler echocardiography]. Ann Ital Med Int 1992, 7(3):141-147.
39. Saccà L, Napoli R, Cittadini A: Growth hormone, Acromegaly, and heart failure: an intricate triangulation. Clin Endocrinol (Oxf) 2003, 59(6):660-671.